Arterio-Venous Fistula Calcifications-Risk Factors and Clinical Relevance

Iulia Dana Grosu1,2,3, Oana Stirbu4,5, Adalbert Schiller1,2

  • 1Department of Internal Medicine II-Nephrology University Clinic, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.

Biomedicines
|November 27, 2024
PubMed

Insights

Arterio-venous fistula (AVF) calcifications are common in hemodialysis patients but do not impact fistula function or survival. Longer hemodialysis duration and higher calcium levels are linked to AVF calcifications.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Radiology

Background:

  • Arterio-venous fistulas (AVFs) are the preferred vascular access for hemodialysis (HD).
  • AVF calcifications are an understudied complication, despite HD patients' predisposition to extraosseous calcifications.
  • Understanding AVF calcification prevalence and impact is crucial for managing dialysis patients.

Purpose of the Study:

  • To determine the prevalence of AVF calcifications in maintenance HD patients.
  • To identify risk factors associated with AVF calcifications.
  • To evaluate the 5-year impact of AVF calcifications on fistula functionality and patient mortality.

Main Methods:

  • A 5-year prospective study involving 161 maintenance HD patients.
  • Collection of baseline data: vascular access history, comorbidities, demographics, SGA, and biochemical parameters.
  • AVF ultrasound assessment of blood flow, calcifications, stenoses, and aneurysms.

Main Results:

  • AVF calcification prevalence was 39%.
  • Univariate analysis linked calcifications to other AVF complications, longer AVF/HD vintage, and higher serum calcium/PTH.
  • Multivariate analysis identified longer HD vintage and higher calcium as independent predictors of AVF calcifications.

Conclusions:

  • AVF calcifications are frequent in HD patients.
  • AVF calcifications did not significantly affect 5-year fistula patency.
  • AVF calcifications were not associated with increased 5-year mortality risk.